- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- No more ‘old school’: How Duke Health is reimagining workforce development
- Why private practice dentistry needs a better model
- Chief nurses: Hospital finances improve with nursing investments
- Mississippi health system goes ‘all in’ on Epic with $115M investment
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Ascension Wisconsin CEO to step down
- The hospitals, health systems cutting jobs in 2026
- The hospitals, health systems cutting jobs in 2026
- Nonprofit highlights rural opioid care strategies
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- Wearables data predicts patient engagement: Mayo Clinic study
- Advocate plans largest US hospital drone delivery network
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Indiana system opens $21.7M outpatient center
- Trump administration targets medical school admissions: 4 notes
- EyeSouth Partners continues 2026 expansion with Louisiana practice
- RSV lingers in parts of US even as flu and COVID-19 recede
- Providence narrows operating loss to $486M in 2025
- A huge month for CMS policy
- What the Health? From KFF Health News: A Headless CDC
- GI is exploding with new tech—but how do patients feel about it?
- Maryland physician to pay $500K+ to settle false claims allegations
- Rhode Island oral surgeon launches Congressional campaign
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- Infosys to acquire Optimum Healthcare IT in $465M deal
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- St. Luke’s CFO joins RCM company’s advisory board
- 52 DSOs to know: 2026
- 10 hospitals, health systems looking for CFOs
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- 10 health system rating downgrades
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- North Star’s restructuring moves forward
- Illinois hospital pauses patient care amid payroll challenges
- What the Best-Performing Revenue Cycles Have in Common
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Medicaid work rules and enrollment losses: 6 notes
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
The Centers for Medicare & Medicaid Services (CMS) is almost hopelessly behind in their Medicare Advantage (MA) plan audits, going back to payment year (PY)2018. The new CMS Director, Dr. Mehmet OZ, has directed CMS to audit all eligible MA contracts for each payment year and will invest additional resources to expedite the completion of audits for payment years 2018 through 2024. The savings from these audits should cover their costs:
Dr. Oz Must Tackle MA Fraud, One Insurer at a Time
By Marion Mass - June 09, 2025CMS Director Mehmet Oz just directed the agency to double down on auditing Medicare Advantage (MA) plans to root out waste and fraud. In the same week, Senate Republicans signalled the same scrutiny. Americans should be cheering these moves that could keep Medicare sustainable.
For years, lawmakers and agencies like CMS alike have seen evidence that MA plan insurers routinely overcharge the government by billions, leaving the average taxpayer to foot the bill. This fraud is unacceptable – and it’s just for Congress and the Administration to stomp it out.
Starting with this audit, Director Oz ought to send a clear message to insurers that have practiced rampant abuse of taxpayer dollars: We have zero tolerance for fraud, waste, and abuse.
Medicare Advantage, when created, allowed Medicare patients to have a choice of a private coverage option. But the very makeup of these plans invite insurers to game the system.
Private insurers that run MA plans will take any chance they can to increase their margins and bleed Medicare dry. Countless MA insurers charged the government for diagnoses based on shoddy health screening done in-house, according to a 2021 Inspector General’s report. It’s not a new problem, either – MA overbilling goes back to 2012, when CMS found $12 billion of this fraud under the Obama administration.
The fraud has only ballooned since then. Today, MA insurers bill $140 billion in excess of what treatments were required for U.S. patients, according to the Center for Medicare Advocacy. Some health plans over-bill by up to $5,888 per patient for standard treatments.
Should Americans expect this additional cash flow to go to patients? Of course not. Nearly one-third of all American healthcare expenditures go to administrative costs and fees, according to a survey from the Commonwealth Fund. That means more money towards suits and less to the ‘scrubs’ helping the patients.
The government must take a stand against this misuse of funds. CMS Director Oz is starting now. Here’s a few pointed suggestions.
CMS needs to step in at the root of the problem: “Upcoding.” Medicare Advantage patients are diagnosed with more severe conditions than they actually have, if they even have them at all. The result is a much larger check for the insurers running the MA plans, coming right out of the coffers of American taxpayers.
The worst offenses happen outside the doctor’s office. Insurers often send non-physician employees to patients’ homes, administer “Health Risk Assessments”, which results in the upcoding. United Healthcare, who runs more MA plans and who stands accused of upcoding more than any than any other insurer, employs or is associated with 10% of America’s practicing physicians. It’s hard to imagine that this perverse incentive has not been used by United to help their bottom line.
CMS Director Oz should work with lawmakers to bar insurers from upcoding and mandate that actual non-conflicted physicians perform screenings for insurance purposes. These two simple changes could prevent insurers from ripping off the government – and the government can prevent these insurers from mishandling millions of patients’ illnesses.
Dr. Oz would be wise to have CMS broadcast exactly which insurers are responsible for upcoding, so Americans interested in purchasing Medicare Advantage plans can make well informed choices.
Lastly, large insurance company subsidiaries have a history of unfairly clawing back money in the pharmacy space. Any fraudulently collected upcoded money must be clawed back with deserved impunity.
It’s more important than ever to start now. More than 40 million Americans are expected to enroll in MA plans by 2030. Insurers must be thrilled at the growing opportunity to defraud the government, but policymakers are worried. The more seniors and at-risk patients enrolled in MA plans, the more that lawmakers need to control costs without denying care. Banning practices like upcoding and Health Risk Assessments prevent these costs from spiraling.
Director Oz has in the past been an outspoken advocate for Medicare Advantage. Yet while Oz’s opponents called him out for pushing pro-insurance talking points, this audit shows that he’s anything but a shill. Taking MA reforms a step further allows him make good on his promise to “stop unscrupulous people from stealing from vulnerable Americans.” He and CMS as a whole must hold insurers accountable for their actions to make Medicare as solvent as it can be.
Auditing insurers is a great place to start – but it’s only a start. To fully eradicate this waste, fraud, and abuse, CMS needs to back up its words with actions.
Marion Mass, M.D. is a Bucks County, PA pediatrician and the co-founder of the Practicing Physicians of America.
The CMS Medicare Advantage Audit Press Release:
CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits
Agency Will Begin Auditing All Eligible Medicare Advantage Contracts Each Payment Year and Add Resources to Expedite Completion of 2018 to 2024 AuditsMay 25, 2025
Today, the Centers for Medicare & Medicaid Services (CMS) announced a significant expansion of its auditing efforts for Medicare Advantage (MA) plans. Beginning immediately, CMS will audit all eligible MA contracts for each payment year in all newly initiated audits and invest additional resources to expedite the completion of audits for payment years 2018 through 2024.
“We are committed to crushing fraud, waste and abuse across all federal healthcare programs,” said Dr. Mehmet Oz, CMS Administrator. “While the Administration values the work that Medicare Advantage plans do, it is time CMS faithfully executes its duty to audit these plans and ensure they are billing the government accurately for the coverage they provide to Medicare patients.”
Medicare Advantage plans receive risk-adjusted payments based on the diagnoses they submit for enrollees—meaning higher payments for patients with more serious or chronic conditions. To verify the accuracy of these claims, CMS conducts Risk Adjustment Data Validation (RADV) audits to confirm that diagnoses used for payment are supported by medical records.
Currently, CMS is several years behind in completing these audits. The last significant recovery of MA overpayments occurred following the audit of payment year (PY) 2007, despite federal estimates suggesting MA plans may overbill the government by approximately $17 billion annually. The Medicare Payment Advisory Commission (MedPAC) estimates this figure could be as high as $43 billion per year. CMS’s completed audits for PYs 2011–2013 found between 5% and 8% in overpayments.
To address this backlog, the Trump Administration has introduced a plan to complete all remaining RADV audits for PY 2018 to PY 2024 by early 2026. Key elements of the plan include:
Enhanced Technology: CMS will deploy advanced systems to efficiently review medical records and flag unsupported diagnoses.
Workforce Expansion: CMS will increase its team of medical coders from 40 to approximately 2,000 by September 1, 2025. These coders will manually verify flagged diagnoses to ensure accuracy.
Increased Audit Volume: By leveraging technology, CMS will be able to increase its audits from ~60 MA plans a year to all eligible MA plans each year in all newly initiated audits (approximately 550 MA plans). CMS will also be able to increase from auditing 35 records per health plan per year to between 35 and 200 records per health plan per year in all newly initiated audits based on the size of the health plan. This will help ensure CMS’s audit findings are more reliable and can be appropriately extrapolated as allowed under the RADV final rule.
In addition to these efforts, CMS will collaborate with the Department of Health and Human Services Office of Inspector General (HHS-OIG) to recover uncollected overpayments identified in past audits. CMS reaffirms its commitment to ensuring all Medicare Advantage plans comply with federal requirements and accurately report patient diagnoses used for payment.
It appears that AHIP has enough Republican U.S. Senators kowtowing to kill off any changes in Medicare Advantage. Dr. Oz will certainly get the message:
Republicans back off Medicare changes in GOP megabill
An effort to get savings from reforms to popular Medicare Advantage plans is failing to gain ground in the Senate.By Jordain Carney and Robert King - June 10, 2025
Senate Republicans appear to be popping their own trial balloon on including changes to Medicare as part of their “big beautiful bill.”
The public shift comes after GOP senators caught their own colleagues off guard — and gave Democrats a new political target — when they opened the door last week to going after “waste, fraud and abuse” within the program to capture savings to satisfy their deficit hawks.
But Sen. Kevin Cramer (R-N.D.), who raised the concept after a closed-door conference meeting last week, said in a brief interview Tuesday that he now doesn’t expect Republicans to actually grab one of their third rails as an offset for President Donald Trump’s sweeping megabill.
When asked if he expects Medicare changes to make it into the massive tax and spending package, Cramer replied, “I don’t know that I do. There aren’t many of us courageous enough to talk about it.” He also acknowledged that his previous remarks sparked “a lot of angst.”
Republicans also last week floated potentially including bipartisan legislation from Sens. Bill Cassidy (R-La.) and Jeff Merkley (D-Ore.) that would target overpayment in Medicare Advantage plans, which enables older Americans to buy private plans offering health coverage. It could lead to tens of billions of dollars in savings.
Many GOP senators, however, raised concerns publicly and privately about including language from that bill as part of the larger tax and spending package.
Sen. Josh Hawley (R-Mo.) said Tuesday he’d spoken with Trump directly and the president wasn’t in favor of doing anything on Medicare.
“He said people who play around with Medicare lose elections,” Hawley said.
The major insurance industry group AHIP also weighed in, warning that the bill would lead to higher costs and reductions in benefits. Moderates in the House also sounded the alarm bells that Senate Republicans appeared to be reviving an idea they had earlier rejected as a pay-for in their version of the legislation.
Even members of the Senate Finance Committee poured cold water on the likelihood that it would be included in draft text their panel could release as soon as Friday. The pushback isn’t based on opposition to the proposal itself but questions about if the megabill is the right venue to advance this particular policy.
“There is a lot of work to be done to make sure you don’t have unintended consequences. But I think that is an area for longer-term gain. I don’t know that you can necessarily, in the horizon that we’re operating [in], be able to book some of the savings that may be out there,” said Sen. Thom Tillis (R-N.C.) about the Cassidy-Merkley measure specifically.
Asked if he expected it would be included in the legislation, Sen. John Barrasso (R-Wyo.), the Senate majority whip and a member of the Finance Committee, instead said it would be in the conference’s “discussions.”
Republicans will meet Wednesday to receive a briefing by GOP senators crafting outstanding portions of the bill, including Finance Chair Mike Crapo (R-Idaho).
Cassidy’s office did not immediately return a request for comment on the status of discussions around his policy proposal, but he has previously said his legislation does not cut benefits. Rather, he has argued it would remove tools that Medicare Advantage plans employ to garner higher payments from the federal government by making patients appear sicker than they actually are.
“This addresses an issue both Republicans and Democrats have called waste, fraud and abuse,” Cassidy said Friday.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















